Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

Withdrawn before enrolling · Phase 2

Conditions studied: Atrial Fibrillation

In brief

This study is being done to determine if apixaban is more safe, when compared to warfarin, at reducing the risk of bleeding during CIED procedures.

Key facts

Study ID

NCT02450682

Run by

Mayo Clinic

People needed

0

Starts

2016-02-01

Expected to finish

2017-03-01

Last updated by the study team

2016-01-18

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.